Statins for everyone--(even for those at low risk.) Experts are excited, but the question is whether benefits would outweigh costs.
D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D008297:Male; D009203:Myocardial Infarction / Q000517:prevention & control*; D011322:Primary Prevention / Q000191:economics* / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D020521:Stroke / Q000517:prevention & control*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors